Ingredients in losartan
Searched over 200M research papers
Summary
2 papers analyzed
These studies suggest that losartan contains active ingredients that can be affected by other substances such as Salvianolic acid B and tanshinone IIA, which modulate its metabolism through the induction or inhibition of enzymes CYP3A4/CYP2C9, and that its composition, including degradation products, can be analyzed using HPLC methods.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Ingredients in Losartan
Losartan is a widely used medication for treating high blood pressure and reducing the risk of stroke in individuals with heart disease. Understanding its ingredients and their interactions is crucial for optimizing its therapeutic efficacy and safety.
Active Ingredient: Losartan Potassium
The primary active ingredient in losartan is losartan potassium. This compound belongs to a class of drugs known as angiotensin II receptor antagonists, which help to relax blood vessels and lower blood pressure by blocking the action of angiotensin II, a substance in the body that causes blood vessels to tighten.
Combination with Hydrochlorothiazide
Losartan is often combined with hydrochlorothiazide (HCTZ), a diuretic, to enhance its blood pressure-lowering effects. This combination is marketed under the brand name HYZAAR. Hydrochlorothiazide helps to reduce the amount of water in the body by increasing urine output, which in turn helps to lower blood pressure.
Impurities and Degradates
Both losartan potassium and hydrochlorothiazide have known impurities and degradation products. Losartan potassium has one main impurity and two primary degradates, while hydrochlorothiazide has one major degradate and two common process impurities. These impurities and degradates are carefully monitored and quantified using high-performance liquid chromatography (HPLC) to ensure the safety and efficacy of the medication.
Interaction with Danshen Components
Danshen, derived from the dried root and rhizome of Salvia miltiorrhiza Bunge, is often used in combination with losartan for treating cardiovascular diseases. Two major components of Danshen, salvianolic acid B (SA-B) and tanshinone IIA (Tan IIA), have been shown to affect the pharmacokinetics of losartan. SA-B can induce the metabolism of losartan by increasing the activity and expression of CYP3A4 and CYP2C9 enzymes, leading to a faster breakdown of the drug. Conversely, Tan IIA inhibits these enzymes, slowing down the metabolism of losartan.
Conclusion
Losartan potassium, often combined with hydrochlorothiazide, is a potent medication for managing hypertension. The presence of impurities and degradates in these drugs is closely monitored to ensure patient safety. Additionally, the interaction of losartan with components of Danshen highlights the importance of understanding drug interactions to optimize therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic
